Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talitha R Bakker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Immunology|December 26, 2001
Self-help in T cell recognition?Talitha R Bakker, P Anton van der Merwe
Current Biology : CB|May 27, 2005
Immunology: how do T cells recognize antigen?Kaushik Choudhuri, Alice Kearney, Talitha R Bakker, et al.
European Journal of Immunology|July 13, 2002
Comparison of CD22 binding to native CD45 and synthetic oligosaccharideTalitha R Bakker, Christina Piperi, Elizabeth A Davies, et al.
Nature Immunology|December 24, 2002
CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signalingClaudine Irles, Antony Symons, Frédérique Michel, et al.
Nature Immunology|February 28, 2003
The nature of molecular recognition by T cellsSimon J Davis, Shinji Ikemizu, Edward J Evans, et al.
Oncotarget|December 13, 2017
MP0250, a VEGF and HGF neutralizing DARPin<sup>®</sup> molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor modelsUlrike Fiedler, Savira Ekawardhani, Andreas Cornelius, et al.
Maturitas|January 8, 2026
Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trialZoe Schaedel, Talitha R Bakker, Claudio Bassetti, et al.
Mabs|October 17, 2017
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidateH Kaspar Binz, Talitha R Bakker, Douglas J Phillips, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Immunology|December 26, 2001
Self-help in T cell recognition?Talitha R Bakker, P Anton van der Merwe
Current Biology : CB|May 27, 2005
Immunology: how do T cells recognize antigen?Kaushik Choudhuri, Alice Kearney, Talitha R Bakker, et al.
European Journal of Immunology|July 13, 2002
Comparison of CD22 binding to native CD45 and synthetic oligosaccharideTalitha R Bakker, Christina Piperi, Elizabeth A Davies, et al.
Nature Immunology|December 24, 2002
CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signalingClaudine Irles, Antony Symons, Frédérique Michel, et al.
Nature Immunology|February 28, 2003
The nature of molecular recognition by T cellsSimon J Davis, Shinji Ikemizu, Edward J Evans, et al.
Oncotarget|December 13, 2017
MP0250, a VEGF and HGF neutralizing DARPin<sup>®</sup> molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor modelsUlrike Fiedler, Savira Ekawardhani, Andreas Cornelius, et al.
Maturitas|January 8, 2026
Efficacy and safety of daridorexant for the treatment of insomnia disorder in women of menopausal transition age: Insights from a randomized controlled trialZoe Schaedel, Talitha R Bakker, Claudio Bassetti, et al.
Mabs|October 17, 2017
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidateH Kaspar Binz, Talitha R Bakker, Douglas J Phillips, et al.
Pageof 1